Should Military Veterans Be Classified as High Risk for Prostate Cancer Screening? A Systematic Review and Meta-analysis
Objective To assess the unique risks of prostate cancer among US veterans, and to
advocate for improved care by raising awareness of the gaps in current AUA guidelines that …
advocate for improved care by raising awareness of the gaps in current AUA guidelines that …
Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
ProBio is the first outcome-adaptive platform trial in prostate cancer utilizing a Bayesian
framework to evaluate efficacy within predefined biomarker signatures across systemic …
framework to evaluate efficacy within predefined biomarker signatures across systemic …
Racial and ethnic differences in prostate cancer epidemiology across disease states in the VA
SR Stock, MT Burns, J Waller, AM De Hoedt… - JAMA Network …, 2024 - jamanetwork.com
Importance Prostate cancer (PC) care has evolved rapidly as a result of changes in prostate-
specific antigen testing, novel imaging, and newer treatments. The impact of these changes …
specific antigen testing, novel imaging, and newer treatments. The impact of these changes …
Social determinants of health mediate racial disparities in cardiovascular disease in men with prostate cancer
Background Cardiovascular disease (CVD) is a significant cause of morbidity and mortality
in men with prostate cancer; however, data on racial disparities in CVD outcomes are …
in men with prostate cancer; however, data on racial disparities in CVD outcomes are …
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of
the relevant literature for each recommendation, following the guideline development …
the relevant literature for each recommendation, following the guideline development …
Race has no impact on prostate cancer–specific mortality, when comparing patients with similar risk of other‐cause mortality: An analysis of a population‐based cohort
Background Other‐cause mortality (OCM) can serve as a surrogate for access‐to‐care. The
authors sought to compare prostate cancer–specific mortality (PCSM) in Black versus White …
authors sought to compare prostate cancer–specific mortality (PCSM) in Black versus White …
Delivering High-quality Care for Marginalized Patient Populations in Safety Net Settings
A Milton, AK Narayan - Academic Radiology, 2024 - academicradiology.org
S afety net hospitals and federally qualified health centers represent trusted, community
health centers that perform a unique role in serving marginalized patient populations across …
health centers that perform a unique role in serving marginalized patient populations across …
[PDF][PDF] SALVAGE THERAPY FOR PROSTATE CANCER: AUA/ASTRO/SUO GUIDELINE (2024)
G Panel - 2024 - auanet.org
SALVAGE THERAPY FOR PROSTATE CANCER: AUA/ASTRO/SUO GUIDELINE (2024)
GUIDELINE STATEMENTS Page 1 Copyright © 2024 American Urological Association …
GUIDELINE STATEMENTS Page 1 Copyright © 2024 American Urological Association …